Brivaracetam

Back to search

Molecule Structure

Scientific Name

Brivaracetam

Description of the Drug

Brivaracetam is an anticonvulsant used for the treatment of partial-onset seizures that functions by binding to synaptic vesicle glycoprotein 2A (SV2A) in the brain.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05541

Brand Name(s)

Briviact

Company Owner(s)

Sunshine Lake Pharma Co Ltd, Ucb Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Synaptic vesicle glycoprotein 2A SINGLE PROTEIN MODULATOR CHEMBL1998

Unichem Links

SureChEMBL SCHEMBL122081
PharmGKB PA166153491
DrugBank DB05541
PubChem: Thomson Pharma 14797750
PubChem 9837243
Nikkaji J2.411.659J
BindingDB 50422531
DrugCentral 5068
Guide to Pharmacology 9041
rxnorm BRIVIACT BRIVARACETAM
PubChem: Drugs of the Future 22395457
ChEBI 133013
ZINC ZINC000003979899